{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T21:13:23Z","timestamp":1785186803078,"version":"3.55.0"},"reference-count":24,"publisher":"e-Century Publishing Corporation","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Transl Res"],"DOI":"10.62347\/cuxa2243","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T04:12:41Z","timestamp":1745899961000},"page":"2782-2789","source":"Crossref","is-referenced-by-count":2,"title":["Expression of transient receptor potential vanilloid type 1 (TRPV1) in colonic mucosa of patients with irritable bowel syndrome"],"prefix":"10.62347","volume":"17","author":[{"given":"Boran","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"48694","published-online":{"date-parts":[[2025]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1002\/med.21945","article-title":"Transient receptor potential vanilloid 1 (TRPV1)-independent actions of capsaicin on cellular excitability and ion transport","volume":"43","author":"Oz","year":"2023","unstructured":"Oz M, Lorke DE and Howarth FC. Transient receptor potential vanilloid 1 (TRPV1)-independent actions of capsaicin on cellular excitability and ion transport. Med Res Rev 2023; 43: 1038-1067.","journal-title":"Med Res Rev"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s00210-020-01829-x","article-title":"Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract","volume":"393","author":"Szymaszkiewicz","year":"2020","unstructured":"Szymaszkiewicz A, W&#x142;odarczyk J, Wasilewski A, Di Marzo V, Storr M, Fichna J and Zieli&#x144;ska M. Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract. Naunyn Schmiedebergs Arch Pharmacol 2020; 393: 1357-1364.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Aguilera-Lizarraga J, Hussein H and Boeckxstaens GE. Immune activation in irritable bowel syndrome: what is the evidence? Nat Rev Immunol 2022; 22: 674-686.","DOI":"10.1038\/s41577-022-00700-9"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.cger.2020.08.009","article-title":"Functional bowel disease","volume":"37","author":"Aboubakr","year":"2021","unstructured":"Aboubakr A and Cohen MS. Functional bowel disease. Clin Geriatr Med 2021; 37: 119-129.","journal-title":"Clin Geriatr Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/S2468-1253(20)30217-X","article-title":"Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis","volume":"5","author":"Oka","year":"2020","unstructured":"Oka P, Parr H, Barberio B, Black CJ, Savarino EV and Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2020; 5: 908-917.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Lovell RM and Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol 2012; 10: 712-721, e714.","DOI":"10.1016\/j.cgh.2012.02.029"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/smi.3226","article-title":"Systematic review with meta-analysis: Stress-management interventions for patients with irritable bowel syndrome","volume":"39","author":"Horn","year":"2023","unstructured":"Horn A, Stangl S, Parisi S, Bauer N, Roll J, L&#xF6;ffler C, G&#xE1;gyor I, Haas K, Heuschmann PU, Langhorst J and Keil T. Systematic review with meta-analysis: Stress-management interventions for patients with irritable bowel syndrome. Stress Health 2023; 39: 694-707.","journal-title":"Stress Health"},{"key":"ref7","unstructured":"Flacco ME, Manzoli L, De Giorgio R, Gasbarrini A, Cicchetti A, Bravi F, Altini M, Caio GP and Ursini F. Costs of irritable bowel syndrome in European countries with universal healthcare coverage: a meta-analysis. Eur Rev Med Pharmacol Sci 2019; 23: 2986-3000."},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Sebasti&#xE1;n Domingo JJ. Irritable bowel syndrome. Med Clin (Barc) 2022; 158: 76-81.","DOI":"10.1016\/j.medcle.2021.04.015"},{"key":"ref9","unstructured":"Liu GC and Liu TJ. Research progress of Chinese and Western medicine in the treatment of diarrheal irritable bowel syndrome. Med Recapitulate 2023; 29: 5453-5457."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1097\/MEG.0000000000002441","article-title":"Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice","volume":"34","author":"Cheng","year":"2022","unstructured":"Cheng F, Fan Z, Lin C, Zhu Y, He H, Dai N and Du L. Effect of altered gut microbiota on visceral hypersensitivity of postinfectious irritable bowel syndrome mice. Eur J Gastroenterol Hepatol 2022; 34: 1220-1230.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref11","unstructured":"Cui LK, Li HN, Lu Y, Hai XH, Wang XY and Sun Q. Research progress of intestinal microbiota and intestinal mucosal immunity in the pathogenesis of irritable bowel syndrome. Med Recapitulate 2024; 30: 108-112."},{"key":"ref12","unstructured":"Lian J, Sun LX and Yin WL. Research progress of intestinal microecological imbalance in the pathogenesis of irritable bowel syndrome. Shanxi Med J 2021; 50: 739-742."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/13543776.2021.1854225","article-title":"A patent review of transient receptor potential vanilloid type 1 modulators (2014-present)","volume":"31","author":"Gao","year":"2021","unstructured":"Gao M, Wang Y, Liu L, Qiao Z and Yan L. A patent review of transient receptor potential vanilloid type 1 modulators (2014-present). Expert Opin Ther Pat 2021; 31: 169-187.","journal-title":"Expert Opin Ther Pat"},{"key":"ref14","unstructured":"Liu XY, Li Z, Zhou XY and Guo XH. Biological function of transient receptor potential vanillin subfamily 1 (TRPV1). Prog Biochem Biophys 2023; 50: 437-447."},{"key":"ref15","unstructured":"Xu ZC, Nian YY and Meng XM. The mechanism of TRPV1 in the pathogenesis of gastroesophageal reflux disease. Mod Dig Interventional Diagn Treat 2021; 26: 697-701."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1002\/nau.25376","article-title":"Early in life stressful events induce chronic visceral pain and changes in bladder function in adult female mice through a mechanism involving TRPV1 and alpha 1A adrenoceptors","volume":"43","author":"Matos","year":"2024","unstructured":"Matos R, Santos-Leite L, Cruz F and Charrua A. Early in life stressful events induce chronic visceral pain and changes in bladder function in adult female mice through a mechanism involving TRPV1 and alpha 1A adrenoceptors. Neurourol Urodyn 2024; 43: 533-541.","journal-title":"Neurourol Urodyn"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ and M&#xFC;ller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 Suppl 2: II43-47.","DOI":"10.1136\/gut.45.2008.ii43"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2147\/CEG.S454526","article-title":"An overview of the effects of tenapanor on visceral hypersensitivity in the treatment of irritable bowel syndrome with constipation","volume":"17","author":"Singh","year":"2024","unstructured":"Singh P, Sayuk GS, Rosenbaum DP, Edelstein S, Kozuka K and Chang L. An overview of the effects of tenapanor on visceral hypersensitivity in the treatment of irritable bowel syndrome with constipation. Clin Exp Gastroenterol 2024; 17: 87-96.","journal-title":"Clin Exp Gastroenterol"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Keszthelyi D, Troost FJ, Jonkers DM, Helyes Z, Hamer HM, Ludidi S, Vanhoutvin S, Venema K, Dekker J, Szolcs&#xE1;nyi J and Masclee AA. Alterations in mucosal neuropeptides in patients with irritable bowel syndrome and ulcerative colitis in remission: a role in pain symptom generation? Eur J Pain 2013; 17: 1299-1306.","DOI":"10.1002\/j.1532-2149.2013.00309.x"},{"key":"ref20","unstructured":"Zhao EY, Zhou JW, Chu HY, Lv SJ and Yang YJ. Epidemiology and pathogenic factors of irritable bowel syndrome: a review on research progress. Chin J Publ Heal 2021; 37: 764-768."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejphar.2010.08.019","article-title":"Visceral hypersensitivity induced by activation of transient receptor potential vanilloid type 1 is mediated through the serotonin pathway in rat colon","volume":"647","author":"Qin","year":"2010","unstructured":"Qin HY, Luo JL, Qi SD, Xu HX, Sung JJ and Bian ZX. Visceral hypersensitivity induced by activation of transient receptor potential vanilloid type 1 is mediated through the serotonin pathway in rat colon. Eur J Pharmacol 2010; 647: 75-83.","journal-title":"Eur J Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/S0140-6736(20)31548-8","article-title":"Irritable bowel syndrome","volume":"396","author":"Ford","year":"2020","unstructured":"Ford AC, Sperber AD, Corsetti M and Camilleri M. Irritable bowel syndrome. Lancet 2020; 396: 1675-1688.","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1111\/j.1432-1033.2004.04082.x","article-title":"An update","volume":"271","author":"Cortright","year":"2004","unstructured":"Cortright DN and Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1. An update. Eur J Biochem 2004; 271: 1814-1819.","journal-title":"Eur J Biochem"}],"container-title":["American Journal of Translational Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/4\/ajtr0161126.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:56:24Z","timestamp":1766022984000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajtr\/17\/4\/ajtr0161126.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.62347\/cuxa2243","relation":{},"ISSN":["1943-8141"],"issn-type":[{"value":"1943-8141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}